drugset / Trial / NCT01531452
The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the efficacy and safety of oxaliplatin and s1 as first-line treatment of advanced gastric cancer.
Timeline
- Start
- 2011-06
- Primary completion
- 2012-11
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | 130 mg/m2 | — |
| Subject | s1 [arm: experimental] — 80mg/m2/d, d1-14,repeated q21d | Unknown | 80 mg/m2 | — |